Augmedix has raised a foreign investment of USD 19 million as Series B of venture capital funding.
Augmedix Bangladesh country director Rashed Mujib Noman revealed details on investment at a press meet at its head office in the capital’s Panthapath on Tuesday.
“The main objective of the fundraising is to establish Augmedix as an iconic destination employer for up-and-coming recent graduates,” said Rashed Mujib Noman.
He also said the company will deploy this capital to expand its operations in 2020 and will offer thousands of promising job opportunities for the young graduates of Bangladesh.
According to a press statement, the funding comes from some of the largest tier-1 Silicon Valley investors such as Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments.
The San Francisco-based venture turns the natural clinician-patient conversation into medical documentation, in real-time, so that clinicians can focus on what matters most–patient care.